Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
In this study, the investigator plan to prescribe Methylprednisolone pulse therapy in
Kawasaki disease patients with coronary artery lesions or aneurysm formation beyond acute
stage to investigate the role for vasculitis of KD or regression of dilatation.